What is the outcome for stage 3B squamous cell NSCLC?
Stage 3B non-small cell lung cancer is considered an advanced stage where the cancer has spread more extensively within the chest but hasn't moved to distant organs. For stage 3 NSCLC overall, the five-year survival rate ranges from 9 percent to 37 percent, depending on Show Full Answer
What is the outcome for stage 3B squamous cell NSCLC?
Stage 3B non-small cell lung cancer is considered an advanced stage where the cancer has spread more extensively within the chest but hasn't moved to distant organs. For stage 3 NSCLC overall, the five-year survival rate ranges from 9 percent to 37 percent, depending on how far the cancer has spread.
It's important to understand that survival rates are general statistics and don't predict individual outcomes. Many factors can influence your specific prognosis, including:
- How well your cancer responds to treatment
- Your overall health and fitness level
- Whether you smoke (quitting can improve outcomes even after diagnosis)
- Specific characteristics of your cancer cells
- How well your immune system recognizes the cancer
New treatment options, including immunotherapy and targeted therapies, are helping people with advanced lung cancer live longer and maintain better quality of life. Your healthcare provider can give you a prognosis specific to your situation based on all the details of your diagnosis and health.
December 2, 2025
Join
Your Privacy Choices
